Next Financial Group’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
BBA
AC
CS
Next Financial Group's BLUE Position: Q4 2021 in Review
Next Financial Group reduced its bluebird bio (BLUE) stake by 50% in Q4 2021, selling an estimated $236 and leaving 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2867.
Next Financial Group first reported a position in BLUE in Q2 2014 and has held it in 21 quarters since. The position peaked at $42K in Q2 2015. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.
- Next Financial Group held 1 share of bluebird bio worth $0 as of Q4 2021.
- Next Financial Group sold 1 bluebird bio share in Q4 2021, an estimated $236.
- bluebird bio made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2867 holding.
- Next Financial Group first reported a position in bluebird bio in Q2 2014 and has held it in 21 quarters since.
- Next Financial Group's bluebird bio position peaked at $42K in Q2 2015.
- 172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.
Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.